Effect of diethylcarbamazine on Strongylus vulgaris infection in ponies.
Shetland ponies (n = 4) were given diethylcarbamazine orally at a dose level of 22 mg/kg/day for 1 week before they were inoculated with 800 third-stage larvae of Strongylus vulgaris. Treatment was continued for 86 (1 pony) or 200 days (3 ponies) after the inoculation. As compared with the changes seen in a similarly inoculated group of ponies (group 2) which were not treated, diethylcarbamazine did not prevent the clinical or pathologic changes due to the migrating larvae. Fewer adult parasites were recovered at necropsy from treated ponies than from nontreated (group 2) ponies, even when treatment was discontinued 86 days after inoculation. Treatment appeared to have a detrimental effect on 4th-stage larvae either in the arteries or their intestinal wall, but not until after arterial lesions resulted.
D000818:Animals; D001158:Arteries / Q000473:pathology; D004049:Diethylcarbamazine / Q000627:therapeutic use*; D005243:Feces / Q000469:parasitology; D006736:Horses; D013319:Strongyle Infections, Equine / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D013320:Strongyloidea
D004049:Diethylcarbamazine